March 2, 2023 10:43 AM EST

Valneva reports more data on Covid-19 vaccine; ClinChoice buys a CRO

Kyle LaHucik

Senior Reporter

Paul Schloesser

Associate Editor

Valneva presented updates on its Covid-19 vaccine, the first to get the full marketing green light in Europe, but the French biotech stopped manufacturing of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Valneva reports more data on Covid-19 vaccine; ClinChoice buys a CRO

Kyle LaHucik

Senior Reporter

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Are programs with compounded GLP-1s safe for your population?

Val­ne­va re­ports more da­ta on Covid-19 vac­cine; Clin­Choice buys a CRO

Senior Reporter

Associate Editor

Sign up to read this article for free.

Valneva reports more data on Covid-19 vaccine; ClinChoice buys a CRO